Number Needed to Treat, Explained
A friendly numeracy guide to what NNT means, how to read it, and how to use it when deciding whether a treatment is worth it for you.
Number needed to treat, or NNT, is a plain way to describe how well a treatment works. It tells you how many people would need to take a treatment for one additional person to benefit. A smaller number means the treatment helps more readily; a larger number means fewer people gain from it. NNT turns a study result into a human count you can reason about.
What does number needed to treat actually mean?
Imagine a treatment that prevents one heart attack for every 50 people who take it over a few years. The NNT is 50. That does not mean the other 49 people were harmed or wasted their time. It means that, based on the study, one person in that group of 50 got a benefit they would not have had otherwise, and we cannot know in advance which one.
I like NNT because it respects how people naturally think. When a patient asks me, "Doctor, is this actually going to help me?" a percentage can feel abstract. A count of people feels closer to real life. It reframes the question from "does this work in general" to "how much work does this treatment do per person who takes it."
Can you show a simple worked example?
Say a study follows two groups for one year. In the group that did not get the treatment, 10 out of 100 people had the outcome we wanted to prevent. In the treated group, only 6 out of 100 had it. The treatment lowered the rate from 10 percent to 6 percent, an absolute drop of 4 percentage points.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trialTo get the NNT, you take 1 and divide it by that absolute difference expressed as a fraction. One divided by 0.04 equals 25. So the NNT is 25: about 25 people take the treatment for one extra person to avoid the outcome over that year. That is the whole calculation. No advanced math, just division.
Why is a small NNT strong and a large one weaker?
The lower the number, the more reliably a treatment delivers. An NNT of 5 means one in every five people benefits, which is a strong signal. An NNT of 300 means the benefit is real but spread thin across a large group. Neither is automatically good or bad. A large NNT can still be worthwhile if the outcome being prevented is serious and the treatment is cheap and safe. A small NNT for a minor benefit, paired with real side effects, might not be worth it.
This is where judgment enters. NNT gives you the size of the benefit. You then weigh it against the burden: cost, effort, side effects, and how much the outcome matters to you personally.
How does NNT fit with relative and absolute risk?
These three ideas are teammates. Relative risk tells you the proportional change, such as "risk cut by 40 percent." That sounds dramatic, but it hides how common the outcome was to begin with. Absolute risk tells you the actual percentage-point difference, like the 4 points in the example above. NNT then translates that absolute difference into a headcount.
A quick habit worth keeping: whenever you see a bold "cuts risk by half" claim, look for the absolute numbers behind it. Cutting a risk from 2 percent to 1 percent is a 50 percent relative reduction, but the absolute change is 1 point, and the NNT is 100. The same headline can describe a large benefit or a modest one, and NNT is what tells them apart.
Why does NNT help you decide if a treatment is worth it?
Because it puts benefit and cost on the same table. In weight and metabolic care, we often pair a treatment's expected benefit against its side-effect profile. Take GLP-1 medicines: in the pivotal trials, the most common side effects were gastrointestinal, with nausea most frequent (for example, roughly 44 percent with semaglutide 2.4 mg versus about 25 percent on placebo in the STEP program, and roughly 24 to 39 percent with tirzepatide depending on dose). Most of those effects were mild to moderate and tended to peak in the first one to four weeks after each dose increase, then ease as the body adapted.
When you can see both the likely benefit and the likely burden in plain numbers, the decision becomes yours to make with your clinician, rather than something handed down. That is the whole point of numeracy: not to memorize statistics, but to feel in control of your own choices.
What are the limits of number needed to treat?
NNT is an average built from a specific study population over a specific time. Your situation may differ. If your baseline risk is higher than the study group's, the treatment may help you more, giving you a lower personal NNT. If your baseline risk is lower, the reverse can be true. NNT also depends heavily on the time frame; a one-year NNT and a five-year NNT for the same treatment are different numbers, so always ask "over how long."
It also cannot capture how much you value a given outcome, or side effects that matter to you but not to the average person. And a single trial's NNT can shift as more evidence arrives. So treat it as a strong compass, not a fixed verdict. I always tell patients that a number informs a decision; it does not make the decision, and a clinician confirms what applies to you rather than any single figure.
How should you ask your clinician about NNT?
You do not need special language. A few plain questions open the door: "How many people like me would need this treatment for one to benefit?" "Over what time period?" "What is the absolute benefit, not just the relative one?" "What is the chance of side effects, and how do they compare to the benefit?" A good clinician welcomes these. In my practice, the conversations I trust most are the ones where a patient pushes on the numbers, because that is how a decision becomes truly shared.
If you want a calm, unhurried version of that conversation about metabolic health or weight care, a consult with Dr. Anjmun Sharma, MD at New Hope Weight Loss and Wellness is a place to have it. The clinic is cash-pay, telehealth, and private, and a visit is $119. We will look at the evidence together, in plain numbers, and decide what is genuinely worth it for you.
Frequently asked questions
Is a low number needed to treat always better than a high one?
A low NNT means a treatment helps more people per person treated, which is a strong signal. But a higher NNT can still be worthwhile if the outcome being prevented is serious and the treatment is safe, low-cost, and easy. NNT tells you the size of the benefit; you weigh it against burden, cost, and how much the outcome matters to you. A clinician helps you judge what applies to your situation.
How do I calculate NNT from a study myself?
Find the outcome rate in the untreated group and the treated group, then subtract to get the absolute difference. Divide 1 by that difference expressed as a fraction. For example, if the rate falls from 10 percent to 6 percent, that is a 4-point drop, or 0.04. One divided by 0.04 is 25, so the NNT is 25. Always note the time period the study covered, since NNT changes with time.
What is the difference between NNT and relative risk reduction?
Relative risk reduction gives a proportional change, like risk cut by 40 percent, which can sound large even when the underlying event is rare. NNT is built from the absolute difference and tells you how many people must be treated for one to benefit. Whenever you see a bold relative claim, look for the absolute numbers behind it; that is what lets you tell a big benefit from a modest one.
Does my personal NNT match the number from a trial?
Not exactly. Trial NNT is an average from a specific population over a set time. If your baseline risk is higher than the study group's, a treatment may help you more, lowering your personal NNT; if your risk is lower, the reverse can hold. Your values, side-effect tolerance, and time horizon also matter. Treat trial NNT as a strong compass, and let a clinician confirm what fits you.
Should NNT alone decide whether I take a treatment?
No. NNT is one useful input, not the whole decision. It does not capture how much you value a given outcome, side effects that matter specifically to you, or how the evidence may shift as more studies arrive. Pair it with the side-effect profile, cost, effort, and your own priorities. A shared conversation with your clinician, using plain numbers, is the best way to reach a decision you trust.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.